Antiviral drugs in current clinical use | Journal of Clinical Virology | 2004 | 758 |
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine | Biochemical and Biophysical Research Communications | 2004 | 441 |
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection | Journal of Acquired Immune Deficiency Syndromes (1999) | 2004 | 312 |
Antivirals and antiviral strategies | Nature Reviews Microbiology | 2004 | 275 |
Non-nucleoside reverse transcriptase inhibitors (NNRTIs): past, present, and future | Chemistry and Biodiversity | 2004 | 198 |
Susceptibility of HIV-2, Siv and Shiv to Various Anti-HIV-1 Compounds: Implications for Treatment and Postexposure Prophylaxis | Antiviral Therapy | 2004 | 161 |
Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid | Journal of Pathology | 2004 | 140 |
A sequence-independent strategy for detection and cloning of circular DNA virus genomes by using multiply primed rolling-circle amplification | Journal of Virology | 2004 | 137 |
Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection | Antimicrobial Agents and Chemotherapy | 2004 | 135 |
In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides | Antimicrobial Agents and Chemotherapy | 2004 | 130 |
Hantaviruses: immunology, treatment, and prevention | Viral Immunology | 2004 | 121 |
Synthesis and antiviral evaluation of benzimidazoles, quinoxalines and indoles from dehydroabietic acid | Bioorganic and Medicinal Chemistry | 2004 | 114 |
Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1 | Current Topics in Medicinal Chemistry | 2004 | 113 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound | International Journal of Infectious Diseases | 2004 | 101 |
Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster | Biochemical Pharmacology | 2004 | 99 |
Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis | Antiviral Therapy | 2004 | 96 |
Molecular evolution and circulation patterns of human respiratory syncytial virus subgroup a: positively selected sites in the attachment g glycoprotein | Journal of Virology | 2004 | 95 |
Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration | Journal of Leukocyte Biology | 2004 | 89 |
The molecular population genetics of HIV-1 group O | Genetics | 2004 | 89 |
HIV-chemotherapy and -prophylaxis: new drugs, leads and approaches | International Journal of Biochemistry and Cell Biology | 2004 | 87 |
Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins | Journal of Virology | 2004 | 82 |
2-(2,6-Dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors | Antiviral Research | 2004 | 82 |
Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist | Journal of Virology | 2004 | 76 |
Updated European Recommendations for the Clinical Use of HIV Drug Resistance Testing | Antiviral Therapy | 2004 | 73 |
Polyomavirus infection in pediatric renal transplant recipients: evaluation using a quantitative real-time PCR technique | Pediatric Transplantation | 2004 | 71 |